Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone target-controlled postoperative analgesia with intraoperative sufentanil interaction modeling after elective cardiac surgery
2011-003648-31Phase 4Completed
- Sponsor
- Universitätsklinikum Erlangen
- Start
- Aug 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydromorphone, sufentanil in postoperative pain, sponsored by Universitätsklinikum Erlangen. Started Aug 2011; status: completed.
02
Drugs
hydromorphonesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2011-003648-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003648-31.